Friday 18 September 2015

Erdafitinib


INN name:
Erdafitinib
Lab codes:
JNJ-42756493
Chemical name:
N1-(3,5-dimethoxyphenyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]-N2-(propan-2-yl)ethane-1,2-diamine
Molecular formula:
C25H30N6O2
Chemical Structure:
CAS Registry Number:
1346242-81-6
Originator:
Astex Therapeutics
Developer:
Janssen Research & Development
Class:
Antineoplastics
Mechanism of Action:
Fibroblast growth factor receptor antagonists
WHO ATC code:
L01 (Antineoplastic Agents)
EPhMRA code:
L1 (Antineoplastics)

Clinical Trials:

Conditions
Phases
Status
Urothelial Cancer
Phase 2
Recruiting
Tumor or Lymphoma
Phase 1
Recruiting
Neoplasms;   Lymphoma;   Adenocarcinoma;   Esophagogastric Junction
Phase 1
Recruiting
Carcinoma, Hepatocellular
Phase 1
Recruiting

Recent activities on the drug:
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)